You've pitched fifteen investors. You've heard "come back when you have more traction" a hundred-eleven times. And you're starting to wonder if the problem is you, your deck, your story, your timing. It's not. The problem is the capital stack you've been told to pursue is structurally misaligned with the stage you're actually in.

There is a $5 billion-a-year government program that has been funding pre-revenue, pre-MVP technology startups since 1982. It takes zero equity. You keep your IP. The government doesn't want a board seat or day-to-day control. They fund you, you solve the problem, and they get the indirect return of jobs, innovation, and tax revenue down the line. It's called SBIR and most founders have never seriously looked at it.

This week I'm talking to Jerry Hollister, who spent nearly a decade helping a company pull in $50M in government funding to develop cancer treatment technology when every VC and angel said no. That same company now has a $120M supply agreement with Novartis — the largest radiopharmaceutical company in the world — plus deals with AstraZeneca and Bayer. Jerry has since helped technology companies across 30 states navigate the same path. He also serves as a reviewer for four of the eleven SBIR agencies, so he knows what's on the scoring sheet from both sides.

What we break down:

• The three scoring criteria every SBIR application is graded on: Science, team, and commercial pathway — and why most technical founders fail on criteria two and three
• What "traction" looks like before you have revenue: Pilots, letters of support, contingent purchase orders — and why customer discovery that causes you to pivot is actually proof of readiness
• The free government resource most founders have never heard of: The FAST Program, which funds professional SBIR consulting in every state at little to no cost to founders
• Why this is a both/and capital strategy: How to think about SBIR alongside private capital — and the story of the $30M Novartis equity deal they turned down
• The SBIR reauthorization drama and what it means now: The program expired, sat dormant through a government shutdown and months of political chaos, and was finally signed for six more years in April

This episode is for you if you're building a technology-based company, you're pre-revenue or pre-MVP, and you've been told by private investors you're too early or you've been raising for a while and need to understand every legitimate capital option on the table.

Ready to go deeper? This week's Growth Playbook breaks down how to evaluate whether your company qualifies, what reviewers are actually scoring, how to build the team composition that wins, and how to find free consulting support in every state.

Subscribe on Substack and you get the full playbook plus access to The Collective — our private founder community where you can bring your specific questions and keep building alongside people doing the same work. Become a paid subscriber and get this week's playbook HERE:https://shegetsshitdone.substack.com/